Cargando…

Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study

INTRODUCTION: Immune-mediated inflammatory diseases (IMIDs) cause significant impairment in quality of life. Although they share similar genetic factors, environmental precipitants, and pathophysiological mechanisms, there is little evidence on the risk of developing subsequent IMIDs after an initia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aletaha, Daniel, Epstein, Andrew J., Skup, Martha, Zueger, Patrick, Garg, Vishvas, Panaccione, Remo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824390/ https://www.ncbi.nlm.nih.gov/pubmed/31102202 http://dx.doi.org/10.1007/s12325-019-00964-z

Ejemplares similares

Economic Impact of Non-Medical Switching from Originator Biologics to Biosimilars: A Systematic Literature Review
por: Liu, Yifei, et al.
Publicado: (2019)

Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients
por: Aletaha, Daniel, et al.
Publicado: (2017)

Healthcare Resource Use in Patients with Immune-Mediated Conditions Treated with Targeted Immunomodulators During COVID-19 Pandemic: A Retrospective Claims Analysis
por: Bergman, Martin, et al.
Publicado: (2021)

Noninsulin pharmacological management of type 1 diabetes mellitus
por: Garg, Vishvas
Publicado: (2011)

Health economic evaluation of dipeptidyl peptidase-4 inhibitors
por: Garg, Vishvas
Publicado: (2011)

A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis
por: Edwards, Christopher J., et al.
Publicado: (2020)

The Great Debate With IBD Biosimilars: Con: Biosimilars Should Not Be Routinely Used as a First Line Biologic and Not Switched From Reference Biologics
por: Panaccione, Remo
Publicado: (2021)

Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison
por: Strand, Vibeke, et al.
Publicado: (2017)

Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3
por: Colombel, Jean-Frederic, et al.
Publicado: (2014)

Machine Learning for Predicting Micro- and Macrovascular Complications in Individuals With Prediabetes or Diabetes: Retrospective Cohort Study
por: Schallmoser, Simon, et al.
Publicado: (2023)

Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysis
por: Kotze, Paulo Gustavo, et al.
Publicado: (2018)

One-Year Medication Adherence and Persistence in Rheumatoid Arthritis in Clinical Practice: A Retrospective Analysis of Upadacitinib, Adalimumab, Baricitinib, and Tofacitinib
por: Bergman, Martin, et al.
Publicado: (2023)

Update on the role of upadacitinib in the treatment of adults with moderately to severely active ulcerative colitis
por: Ernest-Suarez, Kenneth, et al.
Publicado: (2023)

The Clinical Implications of Nocebo Effects for Biosimilar Therapy
por: Colloca, Luana, et al.
Publicado: (2019)

Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA
por: Travis, Simon, et al.
Publicado: (2017)

Are gastric hyperplastic polyps an additional manifestation in celiac disease?: Results from a retrospective study
por: Dore, Maria Pina, et al.
Publicado: (2017)

Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study
por: Galloway, James, et al.
Publicado: (2020)

Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study
por: Morgan, Christopher Ll, et al.
Publicado: (2013)

Gastrointestinal manifestations of synthetic cannabinoids: a retrospective cohort study
por: Hakimian, David, et al.
Publicado: (2021)

Additive effectiveness of acrylonitrile‐co‐methallyl sulfonate surface‐treated membranes in the treatment of pneumonia: A propensity score‐matched retrospective cohort study
por: Hayashi, Kentaro, et al.
Publicado: (2022)

Diseases with oral manifestations among adult asthmatics in Finland: a population-based matched cohort study
por: Lemmetyinen, Riikka, et al.
Publicado: (2021)

Neutrinos at the LHC
por: Pandey, Vishvas
Publicado: (2022)

Clinical utility of ustekinumab in Crohn’s disease
por: Kotze, Paulo Gustavo, et al.
Publicado: (2018)

The old versus the new: which do you keep in postoperative Crohn's disease?
por: Kotze, Paulo Gustavo, et al.
Publicado: (2018)

Cutaneous Manifestations of Anabolic-Androgenic Steroid Use in Bodybuilders and the Dermatologist’s Role in Patient Care
por: Furth, Garrett, et al.
Publicado: (2023)

Statins and renal disease progression, ophthalmic manifestations, and neurological manifestations in veterans with diabetes: A retrospective cohort study
por: Mansi, Ishak A., et al.
Publicado: (2022)

Main Oral Manifestations in Immune-Mediated and Inflammatory Rheumatic Diseases
por: Gualtierotti, Roberta, et al.
Publicado: (2018)

An Additive Effect of Oral N-Acetyl Cysteine on Eradication of Helicobacter pylori
por: Hamidian, Seyed Mohammad-Taghi, et al.
Publicado: (2015)

Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls
por: Kotze, Paulo Gustavo, et al.
Publicado: (2017)

Addition of anaerobic coverage for treatment of biliary tract infections: a propensity score-matched cohort study
por: Simeonova, Marina, et al.
Publicado: (2023)

Neurological manifestations as prognostic factors in COVID-19: a retrospective cohort study
por: Sampaio Rocha-Filho, Pedro Augusto, et al.
Publicado: (2022)

Nutrition Center of Excellence (COE) in Inflammatory Bowel Disease—A Model and Rationale for Development
por: Shommu, Nusrat S, et al.
Publicado: (2019)

Relevance of monitoring transmural disease activity in patients with Crohn’s disease: current status and future perspectives
por: Wilkens, Rune, et al.
Publicado: (2021)

Atopic manifestations of inborn errors of immunity
por: Sams, Laura, et al.
Publicado: (2023)

Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care
por: Syed, Umer, et al.
Publicado: (2023)

Additional Anomalies in Children with Gastroschisis and Omphalocele: A Retrospective Cohort Study
por: Pijpers, Adinda G. H., et al.
Publicado: (2023)

Gout, anxiety, and depression in primary care: a matched retrospective cohort study
por: Prior, JA, et al.
Publicado: (2015)

Spironolactone use and risk of incident cancers: a retrospective, matched cohort study
por: Mackenzie, Isla S., et al.
Publicado: (2016)

Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis
por: Ignatius, Elisa H, et al.
Publicado: (2020)

Risk of immune-mediated inflammatory diseases in newly diagnosed ankylosing spondylitis patients: a population-based matched cohort study
por: Chen, Hsin-Hua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_067360ea0mbmr35251rv5422j7